GEN Exclusives

More »

GEN News Highlights

More »
Apr 26, 2011

Cepheid Eyes Two-Week Shipping for Xpert Flu Diagnostic in the U.S.

  • Cepheid expects to have its Xpert® Flu diagnostic available for shipping in two weeks, after receiving FDA clearance to market the product.The test, which runs on Cepheid's GeneXpert® System, detects and differentiates influenza A, influenza B, and the 2009 H1N1 influenza virus simultaneously in about one hour.

    "While molecular testing is widely recognized as the new gold standard for detection of influenza, it has generally been limited to highly complex laboratories,” Cepheid CEO John L. Bishop states. 'Xpert Flu empowers institutions with moderate complexity laboratories to have a molecular influenza test available to their physicians 24 hours a day."

    Xpert Flu requires less than two minutes hands-on time and uses a single-use cartridge design that enables on-demand STAT testing, according to Cepheid. It is also available as a CE mark in vitro diagnostic product.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?